Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

An in-depth Assessment of the Top Drugs Launche...

Progress is driven by innovation. When it comes to developing novel medications and therapeutic biological products, the FDA's Center for Drug Evaluation and Research (CDER) assists the pharmaceuti...

Nov 01, 2021

HIV-1-treatment-market
Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently. Some of the major changes include the preference of single-tablet regimens (STRs) over multiple tablet regimens (MTRs), tenofovir alafenamide (TAF)-based therapies over tenofovir disoproxil fumarate (TDF)-based therapies, integr...

Find More
von-willebrand-disease-vwd-market
von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improperly. Blood contains numerous proteins that aid in blood clotting when necessary. Von Willebrand factor is one of these proteins (VWF). VWD patients have either a low level of VWF in their blood or the VWF protein does not functi...

Find More
companies-in-gene-therapy-for-dermatology
Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology Segment

Advances in genetics research have sparked a surge in interest in gene therapy in dermatology in recent years. Dermatology treatment options have expanded beyond topical drugs to include oral medications, injectables, and light and laser therapy. Now, rather than simply treating symptoms, gene therapy in dermatolog...

Find More

More Views & Analysis

gene-therapies-in-dermatology
Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discovery, conceptualization in 1972, and successful application in 1990 by W. French Anderson, gene therapy has been a revolutionary game-changer in the field of biotechnology and healthcare. Now, its scope reaches beyond autoimmune...

Find More

heart-failure-market
Mapping the Increasing Burden of Heart Failure: What Does it Bring for Healthcare Market Companies?

Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition in which the heart muscle fails to pump blood as efficiently as it should. This causes an accumulation of blood and fluid in the lungs, resulting in shortness of breath. Certain heart conditions, such as narrowed arteries in the ...

Find More

Bone Metastasis Market
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is considered to be - the bone. Bone Metastasis occurs when cancerous cells from the primary tumor relocate to the bone. Although almost all cancers can spread to the bone, Bone Metastasis is most commonly observed in breast, prostat...

Find More

Digital-Therapeutics-for-depression
Evaluating the Role of Digital Therapeutics as an Alternative to Conventional Therapies for Depression

Depression is a mental condition characterized by prolonged series of poor moods, loss of interest and enjoyment in ordinary activities, and low energy, all of which contribute to varying degrees of social and vocational dysfunction. Depression is a chronic condition that affects a person's ability to work, quality...

Find More

myocardial-infarction-market-treatment-growth-size-therapies-forecast-key-companies
Increasing Incidence, Influx of Companies add to the Market Revenue in the Myocardial Infarction Market Space

Myocardial infarction is an irreversible death of heart muscles. It is pathologically referred to as myocardial cell death due to a prolonged lack of oxygen supply (ischemia). The condition is accompanied by chest pain that may appear as a sensation of tightness or pressure initially attributable to diminished cell...

Find More

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical muscle contractions from occurring, resulting in muscle weakness. This disease is associated with antibodies directed a...

Find More

Axial Spondyloarthritis (axSpA) is an umbrella term for a form of inflammatory form of arthritis ass.....

Find More

Managing patients virtually, the most important healthcare trend of 2020, is a process where healthc.....

Find More

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Find More

Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of Pulmonary Hyperten.....

Find More

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Find More

The Union of the European countries, also known as the European Union or the EU, is more or less lik.....

Find More